Community Pharmacy Practice in Italy during the COVID-19 (SARS-CoV-2) Pandemic: Regulatory Changes and a Cross-Sectional Analysis of Seroprevalence.
COVID-19
Italy
SARS-CoV-2
community pharmacies
pharmacists
safety measures
seroprevalence
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
26 02 2021
26 02 2021
Historique:
received:
21
01
2021
revised:
19
02
2021
accepted:
22
02
2021
entrez:
3
3
2021
pubmed:
4
3
2021
medline:
6
3
2021
Statut:
epublish
Résumé
Pharmacists in the community and the essential requirement to safeguard their own health have become fundamental since the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The aims of this paper were (I) to analyze the directives provided to pharmacists in 2020 regarding preventative safety measures to be adopted; (II) to determine the number of pharmacists who came into contact with SARS-CoV-2 in North-West Italy and relate this to the adopted preventative measures. The first aim was pursued by conducting a bibliographic research, consulting the principal regulatory sources. The second one was achieved with an observational study by administering a questionnaire and performing a serological test. The various protection measures imposed by national and regional legislation were analyzed. Two hundred and eighty-six pharmacists (about 8% of the invited ones) responded to the survey. Ten pharmacists reported a positive result to the serological test. Of the subjects who presented a positive result, three declared that they had not used a hand sanitizer, while two stated that they had not scheduled the cleaning and decontamination of surfaces. Two interviewees had not set up a system of quota restrictions on admissions. In four cases, a certified cleaning company had decontaminated the premises. The results of our study show that during the coronavirus disease 2019 (COVID-19) pandemic, the most pressing challenge for community pharmacists has been the protection of staff and clients inside the pharmacy; the challenge to be faced in the near future will probably be the management of new responsibilities.
Identifiants
pubmed: 33652711
pii: ijerph18052302
doi: 10.3390/ijerph18052302
pmc: PMC7967686
pii:
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Références
Res Social Adm Pharm. 2021 Feb;17(2):456-459
pubmed: 32387229
Clin Microbiol Infect. 2021 Feb;27(2):289.e1-289.e4
pubmed: 33031947
Cochrane Database Syst Rev. 2020 Jun 25;6:CD013652
pubmed: 32584464
Int J Clin Pharm. 2021 Jan 15;:
pubmed: 33449247
Res Social Adm Pharm. 2021 Jan;17(1):1819-1824
pubmed: 32249102
Microorganisms. 2020 Dec 28;9(1):
pubmed: 33379279
Pharmacy (Basel). 2020 Aug 07;8(3):
pubmed: 32784696
Vaccine. 2016 Nov 11;34(47):5708-5723
pubmed: 27765379
Integr Pharm Res Pract. 2015 Jul 01;4:67-77
pubmed: 29354521
Ir J Psychol Med. 2020 Sep;37(3):198-203
pubmed: 32434603
Vaccine. 2016 Nov 4;34(46):5643-5648
pubmed: 27686834
Res Social Adm Pharm. 2021 Jan;17(1):1845-1852
pubmed: 33317763
Vaccines (Basel). 2020 Sep 16;8(3):
pubmed: 32947988